Nurse Practitioner in Mililani, HI Accepting Medicare

5 Nurse Practitioner nurses found. Showing 1 - 5

Miss Mirie Hara, DNP, APRN-RX, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 95-1003 Kahele St, Mililani, HI 96789 Phone: 808-781-8352

Ms. Jessica Rougee, R.N., APRN, RX, NP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 94-364 Hokuala St, #184, Mililani, HI 96789 Phone: 808-206-6878

Chanel Kapualeialoha Paresa, APRN-RX Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 95-230 Halepule Pl, Mililani, HI 96789 Phone: 808-295-5252

Amber Spaulding, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 95-1051 Wikao St, Mililani, HI 96789 Phone: 808-227-4752

Mr. Dave Fields, PMHNP Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 100 Kahelu Ave Ste 232, Mililani, HI 96789 Phone: 818-465-8740    Fax: 725-215-9036

News Archive

Regenstrief partners with MDClone to speed up access to data for medical research

Health care generates vast amounts of data that have the potential to drive medical research and improve health, but unlocking the power of those data for the greater good is often slow and challenging.

Physicians seek strategies to improve the quality of sleep in ICU

The sleep patterns of patients in the intensive care unit are so superficial that they barely spend any time in the restorative stages of sleep that aid in healing, UT Southwestern Medical Center physicians have found.

India sees increase in malaria deaths despite global decline reported by WHO

While the number of malaria deaths has fallen by one-fifth over the past decade globally, according to a report released by Roll Back Malaria on Monday, "India is still recording high numbers of deaths, which some experts say are underestimated," Agence France-Presse reports.

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

​Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.

Read more Medical News

› Verified 8 days ago